Fietz Agnes, Corsi Francesca, Hurst José, Schnichels Sven
Center for Ophthalmology Tübingen, University Eye Hospital Tübingen, 72076 Tübingen, Germany.
Department of Pharmacy, University of Pisa, 56126 Pisa, Italy.
Antioxidants (Basel). 2023 Dec 4;12(12):2072. doi: 10.3390/antiox12122072.
In the digital age, the widespread presence of electronic devices has exposed humans to an exceptional amount of blue light (BL) emitted from screens, LEDs, and other sources. Studies have shown that prolonged exposure to BL could have harmful effects on the visual system and circadian rhythm regulation. BL is known to induce oxidative stress, leading to DNA damage. Emerging research indicates that BL may also induce cell death pathways that involve the tumor-suppressor protein p53. Activated p53 acts as a transcription factor to regulate the expression of genes involved in cell cycle arrest, DNA repair, and apoptosis. This study aimed to explore the implication of p53 in BL-caused retinal damage, shedding light on the potential mechanisms of oxidative-stress-induced retinal diseases. BL-exposed porcine retinal cultures demonstrated increased p53- and caspase-mediated apoptosis, depending on exposure duration. Direct inhibition of p53 via pifithrin α resulted in the prevention of retinal cell death. These findings raise concerns about the long-term consequences of the current daily BL exposure and its potential involvement in various pathological conditions, including oxidative-stress-based retinal diseases like age-related macular degeneration. In addition, this study paves the way for the development of novel therapeutic approaches for oxidative-stress-based retinal diseases.
在数字时代,电子设备的广泛使用使人类暴露于屏幕、发光二极管及其他光源发出的大量蓝光之下。研究表明,长期暴露于蓝光下可能会对视觉系统和昼夜节律调节产生有害影响。已知蓝光会诱导氧化应激,导致DNA损伤。新出现的研究表明,蓝光还可能诱导涉及肿瘤抑制蛋白p53的细胞死亡途径。激活的p53作为一种转录因子,可调节参与细胞周期停滞、DNA修复和细胞凋亡的基因表达。本研究旨在探讨p53在蓝光引起的视网膜损伤中的作用,揭示氧化应激诱导视网膜疾病的潜在机制。暴露于蓝光下的猪视网膜培养物显示,p53和半胱天冬酶介导的细胞凋亡增加,这取决于暴露时间。通过pifithrinα直接抑制p53可预防视网膜细胞死亡。这些发现引发了人们对当前日常蓝光暴露的长期后果及其在各种病理状况中的潜在作用的担忧,包括年龄相关性黄斑变性等基于氧化应激的视网膜疾病。此外,本研究为开发基于氧化应激的视网膜疾病的新型治疗方法铺平了道路。